Navigation Links
Sinovac Reports Unaudited First Quarter 2009 Financial Results
Date:5/15/2009

481,768 718,516 Net income for the period 131,559 2,298,811 Net income attributable to noncontrolling interest (106,880) (738,855) Net income attributable to shareholders $24,679 $1,559,956 Net income for the period $131,559 $2,298,811 Other comprehensive income Foreign currency translation adjustment 64,899 1,282,528 Comprehensive income 196,458 3,581,339 Comprehensive income attributable to noncontrolling Interest 123,043 1,009,418 Comprehensive income attributable to shareholders $73,415 $2,571,921 Earnings per share - basic and diluted $0.00 $0.04 Weighted average number of shares of common stock outstanding Basic 42,890,695 41,088,322 Diluted 42,890,695 41,470,579 SINOVAC BIOTECH LTD. Incorporated in Antigua and Barbuda Consolidated Statements of Cash Flows Three months ended March 31, 2009 and 2008 Unaudited (Expressed in U.S. Dollars) 2009 2008 Cash Flows From Operating Activities Net income for the period $24,679 $1,559,956 Adjustments to reconcile net income to net cash provided (used) by operating activities: - deferred income taxes 157,394 73,181 - gain on disposal of equipment (9,783) -- - stock-based compensation 66,503 16,636 - provision for doubtful accounts
'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
2. Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims
3. Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email: